Michal Shinnar represents a former AstraZeneca executive in a federal lawsuit against the pharmaceutical company alleging retaliation, sex discrimination and the failure to pay an earned bonus.
Filed in the U.S. District Court for the District of Maryland on August 4, 2026, the lawsuit alleges that the executive was retaliated against and ultimately terminated after raising concerns about a costly manufacturing project and reporting alleged mistreatment of women by a senior male scientist.
The plaintiff asserts claims under the Sarbanes-Oxley Act, which protects certain whistleblowers, the anti-retaliation provision of the Maryland False Claims Act, Title VII of the Civil Rights Act of 1964, the Maryland Human Relations Act, the Montgomery County Human Rights Act, and the Maryland Wage Payment and Collection Law. The wage claim concerns a 2024 bonus she alleges she earned but was not fully paid.
The case was featured in Human Resources Director on August 6, 2026, in an article examining the allegations and the alleged role of AstraZeneca’s Human Resources team in the events leading to the executive’s termination.
Read the article “Fired executive says employer’s HR team helped retaliate after she raised concerns” on the Human Resources Director website.
